These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 2477450

  • 1. Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection.
    Barnaba V, Franco A, Alberti A, Balsano C, Benvenuto R, Balsano F.
    J Immunol; 1989 Oct 15; 143(8):2650-5. PubMed ID: 2477450
    [Abstract] [Full Text] [Related]

  • 2. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
    Nayersina R, Fowler P, Guilhot S, Missale G, Cerny A, Schlicht HJ, Vitiello A, Chesnut R, Person JL, Redeker AG, Chisari FV.
    J Immunol; 1993 May 15; 150(10):4659-71. PubMed ID: 7683326
    [Abstract] [Full Text] [Related]

  • 3. Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with Hepatitis B virus.
    Barnaba V, Franco A, Paroli M, Benvenuto R, De Petrillo G, Burgio VL, Santilio I, Balsano C, Bonavita MS, Cappelli G.
    J Immunol; 1994 Mar 15; 152(6):3074-87. PubMed ID: 7511637
    [Abstract] [Full Text] [Related]

  • 4. In vitro T cell immune responses to the preS2 antigen of the hepatitis B virus envelope protein in preS2 + S vaccine recipients. Absence of cross-reactivity of subtypes at a major T cell recognition site.
    Cupps TR, Tibbles J, Hurni WM, Miller WJ, Ellis RW, Milich D, Wetter N.
    J Immunol; 1993 Sep 15; 151(6):3353-60. PubMed ID: 7690803
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Recognition of hepatitis B surface antigen by human T lymphocytes. Proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides.
    Celis E, Ou D, Otvos L.
    J Immunol; 1988 Mar 15; 140(6):1808-15. PubMed ID: 2450132
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice.
    Wirth S, Guidotti LG, Ando K, Schlicht HJ, Chisari FV.
    J Immunol; 1995 Mar 01; 154(5):2504-15. PubMed ID: 7868916
    [Abstract] [Full Text] [Related]

  • 9. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
    Yasukawa M, Zarling JM.
    J Immunol; 1984 Nov 01; 133(5):2736-42. PubMed ID: 6207243
    [Abstract] [Full Text] [Related]

  • 10. Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins.
    Safadi R, Israeli E, Papo O, Shibolet O, Melhem A, Bloch A, Rowe M, Alper R, Klein A, Hemed N, Segol O, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y.
    Am J Gastroenterol; 2003 Nov 01; 98(11):2505-15. PubMed ID: 14638356
    [Abstract] [Full Text] [Related]

  • 11. Discrimination of hepatitis B virus (HBV) subtypes using monoclonal antibodies to the PreS1 and PreS2 domains of the viral envelope.
    Mimms LT, Floreani M, Tyner J, Whitters E, Rosenlof R, Wray L, Goetze A, Sarin V, Eble K.
    Virology; 1990 Jun 01; 176(2):604-19. PubMed ID: 1693248
    [Abstract] [Full Text] [Related]

  • 12. The role of T8 in the cytotoxic activity of cloned cytotoxic T lymphocyte lines specific for class II and class I major histocompatibility complex antigens.
    Spits H, Yssel H, Voordouw A, de Vries JE.
    J Immunol; 1985 Apr 01; 134(4):2294-8. PubMed ID: 2579137
    [Abstract] [Full Text] [Related]

  • 13. Importance of subtype in the immune response to the pre-S(2) region of the hepatitis B surface antigen. II. Synthetic Pre-S(2) immunogen.
    Milich DR, Jones JE, McLachlan A, Bitter G, Moriarty A, Hughes JL.
    J Immunol; 1990 May 01; 144(9):3544-51. PubMed ID: 1691763
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Analysis of the correlation between PreS1-Ag, PreS2-Ag, HBeAg and HBV DNA in the serum of chronic hepatitis B patients].
    Dou YL, Han JH, Li YZ, DI Q, Ni AP.
    Zhonghua Yi Xue Za Zhi; 2007 Jul 24; 87(28):1984-6. PubMed ID: 17923040
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: interaction with HLA and T-cell receptor.
    Bertoletti A, Southwood S, Chesnut R, Sette A, Falco M, Ferrara GB, Penna A, Boni C, Fiaccadori F, Ferrari C.
    Hepatology; 1997 Oct 24; 26(4):1027-34. PubMed ID: 9328331
    [Abstract] [Full Text] [Related]

  • 18. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
    Riedl P, Wieland A, Lamberth K, Buus S, Lemonnier F, Reifenberg K, Reimann J, Schirmbeck R.
    J Immunol; 2009 Jul 01; 183(1):370-80. PubMed ID: 19542448
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hepatitis B virus (HBV)-derived DRB1*0101-restricted CD4 T-cell epitopes help in the development of HBV-specific CD8+ T cells in vivo.
    Bayard F, Malmassari S, Deng Q, Lone YC, Michel ML.
    Vaccine; 2010 May 14; 28(22):3818-26. PubMed ID: 20362206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.